Oppenehimer Initiates AEterna Zentaris At Outperform, $5.50 PT

Oppenheimer has initiated coverage on AEterna Zentaris AEZS with an Outperform rating and $5.50 price target.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Price TargetInitiationAnalyst RatingsAEterna zentarisBiotechnologyHealth CareOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!